Cargando…

Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus

BACKGROUND: Chronic kidney disease (CKD) is highly prevalent but identification of patients at high risk for fast CKD progression before reaching end-stage renal disease in the short-term has been challenging. Whether factors associated with fast progression vary by diabetes status is also not well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Go, Alan S., Yang, Jingrong, Tan, Thida C., Cabrera, Claudia S., Stefansson, Bergur V., Greasley, Peter J., Ordonez, Juan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014002/ https://www.ncbi.nlm.nih.gov/pubmed/29929484 http://dx.doi.org/10.1186/s12882-018-0942-1

Ejemplares similares

Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study
por: Fitzpatrick, Jesse K, et al.
Publicado: (2022)

Acute Kidney Injury Ascertainment Is Affected by the Use of First Inpatient Versus Outpatient Baseline Serum Creatinine
por: Liu, Kathleen D., et al.
Publicado: (2017)

Data from a pooled post hoc analysis of 14 placebo-controlled, dapagliflozin treatment studies in patients with type 2 diabetes with and without anemia at baseline
por: Stefánsson, Bergur V., et al.
Publicado: (2021)

Dialysis therapy and mortality in older adults with heart failure and advanced chronic kidney disease: A high-dimensional propensity-matched cohort study
por: Zheng, Sijie, et al.
Publicado: (2022)

Impact of CKD Progression on Cardiovascular Disease Risk in a Contemporary UK Cohort of Individuals With Diabetes
por: Cabrera, Claudia S., et al.
Publicado: (2020)

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
por: Fioretto, Paola, et al.
Publicado: (2016)

Kidney function, proteinuria and breast arterial calcification in women without clinical cardiovascular disease: The MINERVA study
por: Parikh, Rishi V., et al.
Publicado: (2019)

Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study
por: Budayr, Amer, et al.
Publicado: (2020)

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen
por: Stefánsson, Bergur V., et al.
Publicado: (2011)

Hemodiafiltration Improves Plasma 25-Hepcidin Levels: A Prospective, Randomized, Blinded, Cross-Over Study Comparing Hemodialysis and Hemodiafiltration
por: Stefánsson, Bergur V., et al.
Publicado: (2012)

A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients
por: Cabrera, Claudia, et al.
Publicado: (2015)

Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study
por: Parikh, Rishi V., et al.
Publicado: (2021)

Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers
por: Idzerda, Nienke M A, et al.
Publicado: (2019)

Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
por: Dekkers, Claire C J, et al.
Publicado: (2018)

Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
por: Dekkers, Claire C J, et al.
Publicado: (2018)

Contemporary Management of Prostate Cancer
por: Cotter, Katherine, et al.
Publicado: (2016)

The association between changes in echocardiography and risk of heart failure hospitalizations and death in adults with chronic kidney disease
por: Fitzpatrick, Jesse K., et al.
Publicado: (2023)

Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
por: Cea Soriano, Lucia, et al.
Publicado: (2015)

Anemia and risk for cognitive decline in chronic kidney disease
por: Kurella Tamura, Manjula, et al.
Publicado: (2016)

Research-based versus clinical serum creatinine measurements and the association of acute kidney injury with subsequent kidney function: findings from the Chronic Renal Insufficiency Cohort study
por: Hsu, Raymond K, et al.
Publicado: (2019)

The contemporary role of surgery in kidney cancer
por: Lattouf, J.B., et al.
Publicado: (2009)

Renal haemodynamic response to sodium‐glucose cotransporter‐2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials
por: van der Aart‐van der Beek, Annemarie B., et al.
Publicado: (2021)

Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data
por: Aoki, Yasunori, et al.
Publicado: (2022)

Incidence rates and contemporary trends in primary urethral cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

Predicting Renal Recovery After Dialysis-Requiring Acute Kidney Injury
por: Lee, Benjamin J., et al.
Publicado: (2019)

Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus
por: Shibata, Ryo, et al.
Publicado: (2022)

Representation of Women in Contemporary Kidney Transplant Trials
por: Vinson, A. J., et al.
Publicado: (2023)

Contemporary Reevaluation of Race and Ethnicity With Outcomes in Heart Failure
por: Savitz, Samuel T., et al.
Publicado: (2021)

Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions
por: Johansson, Susanne, et al.
Publicado: (2017)

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis
por: Scholtes, Rosalie A., et al.
Publicado: (2019)

Incident Atrial Fibrillation and Risk of Death in Adults With Chronic Kidney Disease
por: Bansal, Nisha, et al.
Publicado: (2014)

Correction to: Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus
por: Shibata, Ryo, et al.
Publicado: (2022)

Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study
por: Lee, Benjamin J., et al.
Publicado: (2018)

Predictors of Incident Type 2 Diabetes Mellitus in Japanese Americans with Normal Fasting Glucose Level
por: Hwang, You-Cheol, et al.
Publicado: (2018)

Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis
por: Engelbertz, Christiane, et al.
Publicado: (2023)

Tenapanor administration and the activity of the H(+)‐coupled transporter PepT1 in healthy volunteers
por: Johansson, Susanne, et al.
Publicado: (2017)

Treatments for Chronic Kidney Disease: A Systematic Literature Review of Randomized Controlled Trials
por: Garcia Sanchez, Juan Jose, et al.
Publicado: (2021)

Contemporary Burden and Correlates of Symptomatic Paroxysmal Supraventricular Tachycardia
por: Go, Alan S., et al.
Publicado: (2018)

Insulin and the kidneys: a contemporary view on the molecular basis
por: Daza-Arnedo, Rodrigo, et al.
Publicado: (2023)

Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus
por: Yang, Yujin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ietl7n1v5bu2sgfflu3nunub4v